The authors provide novel and important data concerning the lineage relationships and function of RORγt + ILCs (also known as LTi-like cells). They reconcile contradictory data regarding the localization of NKp46 + RORγt + cells in presenting convincing results that NKp46 + RORγt + cells can be found within intestinal tertiary lymphoid clusters such as cryptopatches as well as immature and mature ILFs. Importantly, the specificity of the staining procedure was carefully evaluated using various approaches (e.g., blockade with the cognate antigen, staining of tissues from Ncr1 -/-mice (Satoh-Takayama, 2008; Sanos, 2009; Vonarbourg, 2010) they find constitutive expression of IL-22 to be independent of the commensal microflora while IL-1 signaling in RORγt + ILCs is required. In a final set of experiments, the contribution of IL-22 to the control of infection with Listeria monocytogenes is addressed. Oral infection of mice transgenic for human E-cadherin led to enhanced IL-22 production by RORγt + ILCs as well as IFN-g production by NKp46 + RORγt -cells. While neutralization of IL-22 had no impact on bacterial titers, neutralization of IFN-g led to increased bacterial burden in small intestine, mesenteric LNs and spleen.
Overall, this is a timely and significant piece of work that provides important new data (comparative gene array analysis) and clarifies some of the controversial issues regarding localization and function of RORγt + ILCs. The data seem to be of high quality and support the major conclusions.
The following major concerns should be addressed:
1. The data concerning the localisation of NKp46 + RORγt + cells in the various intestinal lymphoid follicles is compelling. Nevertheless, it should be more explicitly noted that according to the authors' (Luci, 2009) 4. The authors provide data from mice treated with a mix of antibiotics in the drinking water and conclude that constitutive production of IL-22 does not depend on the commensal microflora. This is a contentious issue with reports showing a role of the microflora for development and function of RORγt + ILCs (Satoh-Takayama, 2008; Sanos, 2009; Vonarbourg, 2010) and others reporting their independence (Sawa, 2010) . It seems important to identify the underlying reasons for these disparate results rather than adding another set of controversial data to the literature. One important issue is that germ-free mice were used to assess function of RORγt + ILCs in the previous studies, whereas antibiotic-treated mice are used here. Controls should be provided (microbiological cultures and 16S rRNA analysis) that antibiotic-treated mice are indeed "germ-free" and that these mice do not display signs of intestinal inflammation. In addition, a comparison of IL-22 production by RORγt + ILCs from conventional, germ-free, and recolonized germ-free mice should be performed. The analysis of IL-22 production in such experiments should be expanded to qPCR and ELISA. In addition, the flow cytometry data should be supplemented by analysis of the MFI (mean fluorescence intensity) using a larger cohort of mice.
5. Constitutive production of IL-22 seems to be highly variable between the experiments with high levels of constitutive IL-22 in the experiments represented in Figs. 4D/E and 7B and almost undetectable levels in Fig. 6B . Does this reflect large variations in the constitutive production of IL-22 between different cohorts of mice?
6. Analysis of IL-17A and IL-17F production by RORγt + ILCs (Figs. 4 and 5) should be provided in parallel.
7. In the data presented in Figs. 4 and 5, IL-23 stimulation does not lead to a substantial increase in IL-22 production which is at odds with previous reports showing a dramatic increase of IL-22 production following IL-23 stimulation (Satoh-Takayama, 2008; Cella, 2009; Sanos, 2009 ). An analysis of IL-22 production in mice genetically lacking IL-23 should be provided.
8. Mice lacking MyD88 in non-hematopoietic cells (Fig. 5B) show a substantial reduction of constitutive IL-22 produced by RORγt + ILCs. This seems to indicate that microbiota-derived signals may play a role in inducing IL-22 production. In addition, it is hard to understand how constitutive IL-1 production shall be explained. Is IL-22 production in germ-free mice also IL-1-dependent? These issues should be experimentally addressed.
Minor issues:
1. The population of NKp46 + RORγt -int cells has not received much attention. The authors now provide compelling data that their transcriptome clusters with the population of RORγt + ILCs but is distinct of bona fide NK cells. This is reminiscent of recently published data showing that NKp46 + RORγt + cells can downmodulate RORγt expression to assume distinct phenotypic and functional profiles. The authors may want to consider to discuss their findings in the context of these previous data. In addition, it would be significant to get a better understanding of how these cells transcriptionally differ from the other subsets of RORγt + ILCs and bona fide NK cells.
2. The authors use mice gentically lacking NKp46 that were generated by ENU mutagenesis. If these mice were previously published, a reference should be provided. Otherwise, the generation of these mice and their genetic characterization should be included in the manuscript.
3. Phenotype and function of RORγt + ILCs is much dependent on the tissue context. The authors often use expressions like "gut RORγt + cells" when referring to cells isolated form the lamina propria of the small intestine. Throughout the manuscript and in the figures, it should be more accurately stated from which tissue the cells were isolated from.
Referee #3 (Remarks to the Author):
The manuscript of Reynders reports on some characteristics of two NKp46 + populations in the gut. One expressing RORγt and the other lacking this factor. The paper has three related but different messages. A pan-genomic profiling was used to get insight into the identity of these two sub sets. The results show that these two populations correspond to cells that are related to NK on one and LTi cell on the other hand confirming data of earlier studies using cell fate mapping. In the second part the authors show that the IL-22 production by gut RORγt + cells is driven by IL-1β via IL-1R1 and MyD88. Oral L. monocytogenes was shown to stimulate cytokine production by the NKp46 + populations but only IFNγ contributed to the control of bacteria load. The paper is somewhat preliminary although it represents a lot of work. The genomic profiling for example revealed many genes selectively expressed in RORγt + cell types which could not be assigned to particular functions. One would like to know the functions of at least some of these genes. Thus the genetic profiling was used to confirm existing information but not for identification of novel functions which would increase the impact of the profiling data. The function of the IL-1β in regulating IL-22 production is interesting but the underlying mechanism is unclear.
Specific comments: Fig 2C shows that the gene profiling of NKp46 + RORγtdim cells and RORγthigh cells are different in particular with respect to expression of cluster VII and Cluster II. This is not discussed and in the remainder of the manuscript these two subsets are considered to be the same. The mechanism of the role of IL-1β in constitutive and induced IL-22 production was not investigated. The authors should consider that the absence of MyD88 affects expression of AHR which is known to be essential for IL-22 production by T cells (Veldhoen et al 2008) .
Additional Correspondence 15 March 2011
I have still not heard back from the third referee. We will therefore proceed with the two reports that we have on file.
Looking forward to seeing the revised manuscript Reply to the Reviewer #1:
We have greatly appreciated the positive comments of Reviewer #1 about the novelty and the quality of our data. In the revised version, we have completed our data regarding the localization of NKp46 + ILCs in the small intestine by adding a quantification of these cells in the lamina propria and in the tertiary lymphoid structures. Moreover, we have also modified the results and the discussion following Reviewer #1 comments about the regulation of IL-22 production, in particular by the commensal flora.
A detailed point-by-point list of the modifications made in the revised manuscript is following.
Referee #1 (Remarks to the Author): We thank the reviewer #1 for this suggestion. A quantification of the different gut NKp46 + ILCs in both lamina propria and gut lymphoid aggregates (CPs, ILFs) has been added in the revised version of the manuscript and the related figure (Figure 1, panel H -RORγt + cells, we performed our microarray analysis before the publication of Sawa report, so we could not take in account yet the unexpected heterogeneity of these NKp46 -ILCs. We have now developed more this specific point in the revised version of the manuscript (pages 16-17).
IL-22 production by RORγt
+ ILCs in young mice (Fig. 4A) should be analyzed as well.
Data regarding IL-22 in RORγt + ILCs isolated from fetuses and 2 week-old mice have now been added in the revised version of Figure 4 (Results, page 11). The results show that RORγt + ILCs analyzed in this study are the major IL-22 producers in both fetal and adult life. This is consistent with data recently published by Sawa et al., Nat. Immunol, 2011. In the initial version of Figure 4 , we showed data regarding both germ-free and antibiotic-treated mice. The efficiency of antibiotic treatment used in the elimination of the large majority of gut microbiota was previously demonstrated (Rakoff-Nahoum et al., Cell, 2004; Ivanov et al., Cell Host. Micr. 2008 ). However, we agree with reviewer #1 that the impact of any antibiotic treatment must be compared to that of complete lack of commensal flora in germ-free mice. In order to clarify this topic, we have revised Figure 4 , by removing data on antibiotic-treated mice and by focusing only on results obtained using germ-free mice. Following the timely suggestion of reviewer #1, we now show data regarding IL-22 production in RORγt + ILCs isolated from conventional, germ-free, and recolonized germ-free mice ( Figure 4D , Results page 11). Our findings show that commensal flora exposure is not required for IL-22 production in RORγt + ILCs, but rather dampens it, which is consistent with a recent independent report (Sawa et al. 2011, Nat. Immunol.).
One important issue is that germ

Constitutive production of IL-22 seems to be highly variable between the experiments with high levels of constitutive IL-22 in the experiments represented in Figs. 4D/E and 7B and almost undetectable levels in Fig. 6B. Does this reflect large variations in the constitutive production of IL-22 between different cohorts of mice?
Constitutive production of IL-22 is fairly consistent across different cohorts of animals for a given mouse strain but can vary from one mouse strain to another. In particular, this was observed in Tg hECad mice, where constitutive IL-22 was lower when compared to C57Bl/6 mice. In any case, RORγt + ILCs isolated from Tg hECad mice were found fully competent in their ability to produce IL-22 upon various in vitro and in vivo stimuli, to levels comparable to those observed in C57BL/6 animals.
Analysis of IL-17A and IL-17F production by RORγt + ILCs (Figs. 4 and 5) should be provided in parallel.
By performing qPCR analysis, we observed that IL-17A transcript expression was 5-fold higher in (Satoh-Takayama, 2008; Cella, 2009; Sanos, 2009 ). An analysis of IL-22 production in mice genetically lacking IL-23 should be provided.
In the data presented in Figs. 4 and 5, IL-23 stimulation does not lead to a substantial increase in IL-22 production which is at odds with previous reports showing a dramatic increase of IL-22 production following IL-23 stimulation
Only a slight increase of IL-22 production upon IL-23 stimulation was indeed observed in the experiments with antibiotic-treated mice. However, this turned out to be due to a defective batch of IL-23. These experiments have been removed from the revised version. In all other experiments, IL-23 stimulation substantially increased constitutive IL-22 production in RORγt + ILCs isolated from wild type mice, in agreement with the previous reports mentioned by the reviewer. This was not the case of mutant Myd88 -/-and IL-1R1 -/-mice, in which both constitutive and IL-23-induced IL-22 production were severely affected. Regarding IL-23 deficient mice, others have recently shown that IL-22 production by RORγt + ILCs is not significantly affected in these mice (Sawa et al. 2011, Nat. Immunol.) . (Fig. 5B) Our data in fetuses and in germ-free mice clearly show that commensal flora is not required for constitutive IL-22 production. This issue has been discussed more extensively in the revised version of the manuscript (pages 11 and 17).
Mice lacking MyD88 in non-hematopoietic cells
In addition, it is hard to understand how constitutive IL-1 production shall be explained. Is IL-22 production in germ-free mice also IL-1-dependent? These issues should be experimentally addressed.
New data have been added in the revised version of Figure 5 , showing that blocking of IL-1R1-dependent signals significantly decreases IL-22 production by RORγt + ILCs isolated from the intestines of fetuses and germ-free mice. Hence, IL-22 production in germ-free mice is also IL-1-dependent (Results, page 13). We propose that constitutive IL-1 production could occur as a response to endogenous signals independently of the microbiota, such as metabolic stress, as developed in the discussion (page 18).
[…] NKp46
+ RORγt + cells can downmodulate RORγt expression to assume distinct phenotypic and functional profiles. The authors may want to consider to discuss their findings in the context of these previous data.
In the report from Vonarbourg et al. (Immunity, 2010) , the downregulation of RORγt in NKp46 + RORγt + cells was mainly observed in the large intestine, in the lymph nodes and in the spleen, but barely detectable in the small intestine. In all our studies, we used lamina propria cells isolated exclusively from the small intestine, where the downregulation of RORγt is rare.
In addition, it would be significant to get a better understanding of how these cells transcriptionally differ from the other subsets of RORγt + ILCs and bona fide NK cells.
We initially performed microarray analysis on both NKp46 + RORγt dim and NKp46 + RORγt high cells, as it was possible to identify these two subsets in RORγtEGFP reporter mice. The analysis of microarray data by hierarchical clustering and by functional annotations showed that these two subsets of NKp46 + RORγt + cells cluster together with RORγt + NKp46 -ILCs, behave as a continuum and are transcriptionally different from SI NK cells. Moreover, known biological annotations can be attributed only to a few genes selectively upregulated in NKp46 + RORγt dim (Cluster VII, Figure 2C) , differently from what observed for cluster I. Finally, the distinction of NKp46 + RORγt dim and NKp46 + RORγt high cell subsets appears to be restricted to the RORγtEGFP reporter mouse model. Indeed, in C57Bl/6 mice, NKp46 + RORγt + cells express only high levels of RORγt, comparable to those detected in NKp46 -RORγt + cells. Altogether, these observations suggest that NKp46 + RORγt dim cells are detected only in RORγtEGFP reporter mice and belong to the same subset of SI ILCs as NKp46 + RORγt high cells, which are transcriptionally and functionally closer to LTi than to cNK cells.
The authors use mice genetically lacking NKp46 that were generated by ENU mutagenesis. If these mice were previously published, a reference should be provided. Otherwise, the generation of these mice and their genetic characterization should be included in the manuscript.
A paper regarding the description of this novel mouse model is currently under preparation. For this reason, the data regarding these deficient mice have been removed from the revised version.
Phenotype and function of RORγt + ILCs is much dependent on the tissue context. The authors often use expressions like "gut RORγt + cells" when referring to cells isolated form the lamina propria of the small intestine. Throughout the manuscript and in the figures, it should be more accurately stated from which tissue the cells were isolated from.
We have revised this point throughout the manuscript.
Reply to the Reviewer #3:
Referee #3 (Remarks to the Author): We thank the reviewer # 3 for the suggestions made that helped us to clarify and improve several points in our manuscript. Regarding microarray data analysis, we believe that our current results are not merely a confirmation of fate cell mapping studies made by other groups, but that they do bring important novel information. GSEA analysis reveals NK and LTi transcriptional signatures specific to the different SI ILCs studied. This analysis is already confirmed at the functional level in our paper for one gene: IL-1R1. Consistently with the transcriptional signature shared by fetal and adult RORγt + ILCs, we have now added new data showing that IL-1R1 is required for IL-22 production by these cells in both fetal and adult life (revised version of Figure 5 , Results page 13). It is indeed true that within the transcriptional signatures specific of RORγt + ILCs, the large majority of the genes enclosed have yet no known function. This actually points to the fact that the understanding of the biology of these cell subsets is currently still in its infancy. The extent of the functions that these cells can mediate and their molecular regulation remain largely to be deciphered. We do believe that our transcriptional analysis will benefit the community to generate novel hypotheses to advance our understanding of the biology of RORγt + ILCs. Obviously, studies on the role of several individual genes -in addition to IL1R1 studied here-in the biology of RORγt + ILCs will require long-term investigation. Hence, it is beyond the scope of the present paper.
Specific comments: Fig 2C shows 
The mechanism of the role of IL-1b in constitutive and induced IL-22 production was not investigated. The authors should consider that the absence of MyD88 affects expression of AHR which is known to be essential for IL-22 production by T cells (Veldhoen et al 2008).
As correctly raised by the reviewer # 3, AHR is required for IL-22 production in T cells. Moreover, it was recently reported that IL-1b stimulation of the IL-1R1 + human cells equivalent to mouse NKp46 + RORγt + ILCs sustains both Ahr and Il-22 expression (Hughes et al., Immunity, 2010) . AHR could thus represent a candidate for the signaling cascade downstream of IL-1R1 and involved in IL-22 production by RORγt + ILCs. This point has now been included in the revised version of the discussion (Discussion, page 18). In addition, for referee inspection, we propose data showing that an inhibitor of AHR, the a-naphthoflavone, can reduce both constitutive and cytokine-induced IL-22 production in SI RORγt + ILCs. 
